BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Clinical trials for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER explained in plain language.
Never miss a new study
Get alerted when new BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER trials appear
Sign up with your email to follow new studies for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Withdrawn trial aimed to stop bladder Cancer's return
Disease control TerminatedThis study planned to test whether a new drug called NDV-01 could help prevent cancer from coming back in people with intermediate-risk, non-muscle invasive bladder cancer. Participants would have had their tumors removed and then been randomly assigned to either receive the drug…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Withdrawn trial aimed to save bladders from cancer surgery
Disease control TerminatedThis study planned to test a new bladder cancer treatment called NDV-01 for patients whose cancer returned after standard therapies. The treatment would have been delivered directly into the bladder to try to control the cancer and potentially avoid major surgery. However, the tr…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC